{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:00:35Z","timestamp":1791064835119,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003427","name":"Gout Research Foundation of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005695","name":"Tottori University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25461057"],"award-info":[{"award-number":["25461057"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ijcard.2013.12.039","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T09:00:30Z","timestamp":1388739630000},"page":"398-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure"],"prefix":"10.1016","volume":"171","author":[{"given":"Kazuhide","family":"Ogino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Hisatome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.12.039_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","article-title":"Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure","volume":"30","author":"Swan","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2008.08.081","article-title":"Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure","volume":"53","author":"AlZadjali","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0025","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.2337\/db10-0165","article-title":"The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study","volume":"59","author":"Matsushita","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0045","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0050","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0055","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(82)91506-9","article-title":"Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up","volume":"2","author":"Murphy","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","article-title":"Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects","volume":"300","author":"Carlsen","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1979.tb05903.x","article-title":"The two-period cross-over clinical trial","volume":"8","author":"Hills","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0090","first-page":"755","article-title":"Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?","volume":"8","author":"Shimamoto","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","article-title":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A(1)(c) levels in patients with chronic heart failure","volume":"160","author":"Yamaji","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0110","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0115","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/en.2005-0969","article-title":"Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle","volume":"147","author":"Sell","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2006.02.009","article-title":"Role of hepatic STAT3 in brain-insulin action on hepatic glucose production","volume":"3","author":"Inoue","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0125","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) Study","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.hjh.0000226200.73065.5d","article-title":"Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade","volume":"24","author":"Guo","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0140","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2002-021836","article-title":"Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action","volume":"88","author":"Dandona","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","article-title":"Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients","volume":"42","author":"Koh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0735-1097(99)00594-X","article-title":"Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure","volume":"35","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0160","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0175","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.HYP.0000118586.38323.5b","article-title":"From inflammation to fibrosis: a stiff stretch of highway","volume":"43","author":"Weber","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.12.039_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/HYPERTENSIONAHA.107.104356","article-title":"Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat","volume":"52","author":"DeLano","year":"2008","journal-title":"Hypertension"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313022493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313022493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:34:43Z","timestamp":1759091683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313022493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0167527313022493"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.039","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}